COMPANY INFO
Rejuvenation Technologies Inc. is a biotechnology company founded in 2018 by John Ramunas and Glenn Markov. The company, headquartered in Mountain View, California, has approximately 23 employees and focuses on developing nucleoside-modified TERT mRNA therapeutics to extend telomeres and treat age-related diseases. Their technology aims to safely and rapidly extend telomeres to increase cellular proliferative capacity, targeting regenerative medicine and age-related conditions. The official website is https://rejuvenationtech.com, and the company operates primarily in the drug discovery and biotechnology industries.
Rejuvenation Technologies is a biotechnology company pioneering nucleoside-modified TERT mRNA therapeutics designed to extend telomeres and target age-related diseases. Founded in 2018 and headquartered in Mountain View, California, the company is advancing solutions at the forefront of regenerative medicine and drug discovery.
The Rejuvenation Technologies leadership team comprises experienced scientists and strategic managers with deep roots in biotechnology, genetics, finance, and translational development. Together, Rejuvenation Technologies executives bring decades of expertise in molecular biology, cellular reprogramming, project management, immunology, and operations, ensuring strong company direction and steady progress toward breakthroughs in age-related disease treatment. This diverse management team collaboratively leverages cross-functional insights to strengthen the company's core mission and growth.
John Ramunas is the Founder and CEO of Rejuvenation Technologies, responsible for the overall strategic direction and operational efficiency of the company. He has spearheaded groundbreaking initiatives in the advancement of novel nucleoside-modified TERT mRNA therapeutics, guiding Rejuvenation Technologies’ drive to combat fatal diseases with unmet medical needs and position the company as a leader in regenerative medicine.
John Ramunas holds a Ph.D. from Stanford University and previously served as a postdoctoral researcher at Stanford, specializing in molecular biology and genetics. His rigorous academic training and hands-on experience in biotechnology and regenerative medicine laid the groundwork for his leadership of the Rejuvenation Technologies executive team, making significant contributions to the company’s rapid progress and innovative culture.
Glenn Markov is the Founder and COO of Rejuvenation Technologies, where he manages company operations and leads the implementation of research strategies. Glenn's leadership is instrumental in the company's therapeutic pipeline, leveraging his deep scientific knowledge in genetics and epigenetics of cellular reprogramming to accelerate the development of solutions for age-related conditions.
Glenn Markov earned his Ph.D. from Stanford University and has spent over a decade working in the fields of genetics and epigenetics. His substantial research expertise and business acumen form a solid foundation for his key role in Rejuvenation Technologies management, helping guide the company’s growth from its inception.
Suzana Tulac leads translational development and project management at Rejuvenation Technologies, orchestrating critical aspects of drug development from early discovery through regulatory alignment. She ensures robust project execution by overseeing candidate mRNA-LNP drug product pipelines and coordinating multidisciplinary teams to advance key clinical programs.
Suzana holds a Ph.D. in Molecular and Cell Biology from the University of Zagreb, alongside over 15 years of experience in pharmaceutical research and project management. Having previously worked at Cepheid and at the Regenerative Sciences Institute as a postdoctoral researcher, she brings both scientific and operational savvy to the Rejuvenation Technologies management team and is certified as a Project Management Professional (PMP).
Robin Holbrook is responsible for finance and administration at Rejuvenation Technologies, overseeing budgeting, financial planning, and all administrative operations to support company growth. Robin’s efforts contribute to the company’s continued financial stability and allow scientific teams to operate at maximum capacity.
With more than five years of finance and administration experience in biotechnology, Robin brings a solid track record in financial management and operational support to the Rejuvenation Technologies executive team, with a background rooted in Palo Alto’s fast-paced biotech environment.
Lukasz Wlodarek directs immunology research at Rejuvenation Technologies, focusing on the company's hematopoietic stem cell rejuvenation initiatives and advancing promising therapeutic candidates in immunology. Lukasz applies state-of-the-art mRNA-tLNP technology to enhance the regenerative medicine pipeline.
He earned his Ph.D. in Stem Cell Biology and Regenerative Medicine from the University of Toronto and brings a wealth of experience from previous positions at Overland Pharmaceuticals and Lyell Immunopharma. Lukasz’s scientific publishing track record and hands-on immunology expertise bolster the technical depth of Rejuvenation Technologies leadership.
The Rejuvenation Technologies leadership team is anchored by founders with advanced scientific training and rounded out by directors with extensive backgrounds in research, project management, immunology, and finance. The company's management structure seamlessly integrates scientific innovation with sound operational strategy, ensuring both visionary breakthroughs and disciplined execution. This cohesive executive team is pivotal in translating biotechnology discoveries into industry-leading therapies and driving sustainable company growth.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Rejuvenation Technologies leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.